The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis

Clin Immunol Immunopathol. 1997 May;83(2):173-8. doi: 10.1006/clin.1997.4333.

Abstract

The transcription factor NF-kappa B plays a significant role in inflammatory diseases. In this study we have investigated the expression of activated NF-kappa B p65 subunit in the rat adjuvant arthritis model in a 28-day time-course experiment using immunohistochemistry. The expression of p65 was detected in the synovial lining layer and around the blood vessels in the inflamed synovium as early as Day 3 post-adjuvant injection. The cells that expressed p65 in the synovial lining were thought to be macrophage-like synoviocytes. The expression was stronger in the injected hindpaw than that in the noninjected hindpaw. Dexamethasone treatment at 1 mg/kg p.o. (Days 0-20) suppressed both the hindpaw edema and increase in p65 expression. Withdrawal of the treatment caused increases in both p65 expression and paw volume. Together these suggest that activated NF-kappa B was specifically expressed in the arthritic synovium and may play a significant role in the development of arthritis.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Arthritis, Experimental / metabolism*
  • Dexamethasone / pharmacology*
  • Female
  • Immunohistochemistry
  • NF-kappa B / biosynthesis*
  • Rats
  • Rats, Inbred Lew

Substances

  • Anti-Inflammatory Agents
  • NF-kappa B
  • Dexamethasone